I’ve recently decided to stop taking Aubagio, due to its continued side effects. I now face a very difficult decision: determining which MS-modifying medication to initiate.
At this point, both Copaxone and Aubagio have been eliminated as treatment options. Thankfully, there are several other medications from which to choose. They vary with respect to their potential side effects, as well as long-term efficacy in reducing the degree of disability progression.
In 1993, the year that I was diagnosed with relapsing-remitting MS, there was only one approved disease-modifying medication, Betaseron. I’m very thankful that there are currently many more options to pursue. At the same time, I’m reluctant to embrace the possibility of new adverse effects.
